Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About William Collier

William Collier is recorded as CEO at Arbutus Biopharma Corp (ABUS). The proxy statement of Arbutus Biopharma Corp reports total compensation of $3,385,984 for William Collier in fiscal 2023, including a base salary of $637,100. Disclosed compensation is on record for 5 fiscal years. William Collier has spoken on 3 earnings calls across 1 company, most recently for Arbutus Biopharma Corp on January 5, 2023.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Arbutus Biopharma Corp

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Arbutus Biopharma Corp (ABUS) $637,100 $3,385,984
2022 Arbutus Biopharma Corp (ABUS) $606,800 $2,645,657
2021 Arbutus Biopharma Corp (ABUS) $583,500 $3,215,289
2020 Arbutus Biopharma Corp (ABUS) $566,500 $2,728,324
2019 Arbutus Biopharma Corp (ABUS) $285,577 $2,334,185

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.